SMYD2 and breast cancer: SMYD2 contributes to the progression of TNBC by methylating and activating non-histone protein targets, specifically STAT3 and NF-κB, while also methylating histone substrate proteins, regulating the transcription of numerous BC-associated genes [10,11].